The convergence of corporations and venture funds is not just an amusing analogy. It points to a fundamental shift in the nature of business and employment.

Turns out research, development, manufacturing, and distribution of physical products is capital intensive, and that alone has kept a lot of early stage capital away from investing in such ideas. A decade or so ago, biotech early stage investors innovated by blending Series As and Bs into one bigger financing round to enable biotech startups to hav... See more